Advertisement

Topics

Quadron Cannatech Receives Two Software and Automation Control Panel Contracts from Major US Entertainment Theme Park

20:00 EDT 21 Aug 2017 | Marketwired

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/22/17 -- Quadron Cannatech Corporation (the "Company" or "Quadron") (CSE: QCC)(CSE: QCC.CN)(CNSX: QCC) is pleased to announce that its wholly owned subsidiary, Cybernetic Controls Systems ("Cybernetic"), has secured two software automation and control panel contracts for two rides for a major US entertainment theme park operator.

The US entertainment theme park chose Cybernetic for its expertise, ingenuity and most importantly, flexibility due to the changing requirements and specifications of the contracts requirements.

Rosy Mondin, CEO of Quadron stated, "We are very pleased to announce these purchase orders. The acquisition of Cybernetic provides Quadron a strategic advantage, bringing us diversified revenues, as well as high-tech automation and sensoring expertise, which the Company is integrating into the design and manufacturing of its automated cannabis extraction and processing equipment. This order demonstrates that Cybernetic's automation solutions meet the requirements of the highest standards of public safety and automation technology, and is great recognition of Cybernetics' technical team's ability to deliver custom built solutions for major industries. As companies look to purchase high quality CSA/ETL certified equipment, Cybernetic is in a strong position to meet these high standards."

A division of Quadron, Cybernetic supplies custom or standard machines & control packages and stocks Automation Equipment including VFDs, PLCs, Touch Screens and Sensors; turning large projects into a simple order request. Cybernetic builds machines and control solutions using high quality CSA/ETL certified equipment and standards.

About Quadron: Quadron focuses on ancillary equipment, products and services for the authorized cannabis industry, providing automated extraction and processing solutions, and sales of end user delivery solutions such as vape pens, capsules and other safer consumption solutions for patients.

For more information, visit: www.quadroncannatech.com

On behalf of the Board of Directors of

QUADRON CANNATECH CORPORATION

Rosy Mondin

President and CEO

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.

Contacts: Rosy Mondin President and CEO Investor Relations Contact: KIN Communications Inc. Caleb Jeffries VP, Investor Relations 1-866-684-6730 NEXT ARTICLE

More From BioPortfolio on "Quadron Cannatech Receives Two Software and Automation Control Panel Contracts from Major US Entertainment Theme Park "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...